In 1996, researchers discovered that dehydroevodiamine (4) (DHED, Figure 3), a white crystalline powder of quinazoline alkaloid extracted from Evodiae Fructus (EF), may well inhibit acetylcholinesterase (AChE) in vitro and possessed anti-dementia effects in vivo. Here, ACHE is linked to dementia.